Family-Staff Communication Intervention at the Time of Difficult Treatment Decision Making
NCT ID: NCT00827437
Last Updated: 2012-04-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
401 participants
INTERVENTIONAL
2004-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Bereaved Parent Study
NCT02425787
Pilot Study of a Brief Intervention for Medically Hospitalized Suicide Attempt Survivors
NCT02414763
Family Mediation Program For At-Risk Youth
NCT01944748
Preventing Child Maltreatment Through A Cellular-Phone Technology-Based Parenting Program
NCT01294475
A Pilot Intervention With Families of Children With Special Health Care Needs
NCT02742831
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1.1 To assess the feasibility of delivering the two-part communication intervention. The definition of feasible is that 50% of all interventions are successfully implemented.
1.1.1 To identify all three types of difficult treatment decisions within the defined time frame (thus identifying eligible parents/guardians and obtaining consent within 72 hours after the decision was made), document the study team's ability to successfully implement the intervention before the child's death (obtaining the parent/guardian information and sharing that with the defined staff such that the family achieves the definition of being fully evaluable as a study participant), and document the participation rate by tracking the number of eligible parents/guardians who agree to participate, decline to participate or withdraw from the study.
1.2: To assess staff perceptions of the impact of the communication intervention on staff 1 to 2 weeks after the intervention.
1.2.1 to measure: a) staff recall of the definition of a good parent and the rationale for the decision; b) staff perception of how this knowledge influenced their care for the family; c) staff satisfaction with the verbal and written communication intervention forms; and d) the impact of the communication intervention on team tension and team communication about the parents' decisions.
1.3: To assess the impact of the communication on parents/guardians by recording their perceptions of the positive and negative aspects of the intervention at the time of the intervention and 1 to 3 weeks after the decision making.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Parent Interview
To include the PI, Nursing Research Specialist,Clinical Research Associate or Clinical Nurse Specialist
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Parent Interview
To include the PI, Nursing Research Specialist,Clinical Research Associate or Clinical Nurse Specialist
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 21 years of age and older.
* This study will enroll only parents/guardians who are 21 years of age and older. The investigators clinical experience is that when the parent/guardian is younger, additional adult members of the family are involved in the decision making and that asking a single person to identify him or herself as the primary parent/guardian creates difficulties for the family.
* As a result, no parent/guardian younger than age 21 will be enrolled in this study.
* English-speaking.
* Willing to give written consent to participate.
* The parents/guardians of a child with incurable cancer or a fatal cancer-related condition who is being treated at St. Jude Children's Research Hospital
* The parents/guardians who made an end-of-life decision on behalf of the seriously ill child within the previous 72-hours.
* Eligible staff can be enrolled more than one time and will be:
* English-speaking
* Willing to give written consent to participate
Exclusion Criteria
* Parents who are identified by their attending or social support staff member as likely to find the study too burdensome because of their emotional or mental state.
* Parents who did not make the end-of-life decision (i.e., when the patient made the decision).
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Jude Children's Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
St. Jude Children's Research Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pamela S Hinds, PhD, RN
Role: PRINCIPAL_INVESTIGATOR
St. Jude Children's Research Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Jude Children's Research Hospital
Memphis, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DECID4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.